Interestingly, using CRISPR-Cas9 genome editing, knocking out H19 in NSCs inhibited cellular proliferation as well as neuronal differentiation and survival, resulting in worsening of motor and cognitive deficits post-ischemia. Here, H19 is linked to ischemia.